JBM (Healthcare) Limited (2161.HK)

HKD 1.85

(0.0%)

Market Cap (In HKD)

1.5 Billion

Revenue (In HKD)

648.41 Million

Net Income (In HKD)

130.46 Million

Avg. Volume

601.39 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.86-2.09
PE
-
EPS
-
Beta Value
0.281
ISIN
KYG1090B1077
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Yat Wai Wong
Employee Count
-
Website
https://www.jbmhealthcare.com.hk
Ipo Date
2021-02-05
Details
JBM (Healthcare) Limited, an investment holding company, develops, manufactures, markets, distributes, and sells healthcare and wellness products in Asia. The company offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices; and pharmaceutical products. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong. JBM (Healthcare) Limited is a subsidiary of JBM Group (BVI) Limited.